{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:32:02Z","timestamp":1788485522793,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Cambridge Biomedical Research Centre"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00415-018-8908-6","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T04:46:37Z","timestamp":1527569197000},"page":"1789-1794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The motor and cognitive features of Parkinson\u2019s disease in patients with concurrent Gaucher disease over 2 years: a case series"],"prefix":"10.1007","volume":"265","author":[{"given":"Lucy M.","family":"Collins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline H.","family":"Williams-Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Deegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"issue":"3","key":"8908_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/(SICI)1096-8652(199907)61:3<216::AID-AJH12>3.0.CO;2-B","volume":"61","author":"M Machaczka","year":"1999","unstructured":"Machaczka M, Rucinska M, Skotnicki A, Jurczak W (1999) Parkinson\u2019s syndrome preceding clinical manifestation of Gaucher\u2019s disease. Am J Hematol 61(3):216\u2013217","journal-title":"Am J Hematol"},{"key":"8908_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bcmd.2012.11.011","volume":"50","author":"EB Chetrit","year":"2013","unstructured":"Chetrit EB, Alcalay RN, Steiner-Birmanns B, Altarescu G, Phillips M, Elstein D et al (2013) Phenotype in patients with Gaucher disease and Parkinson disease. Blood Cells Mol Dis 50:218\u2013221","journal-title":"Blood Cells Mol Dis"},{"key":"8908_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/gim.2012.107","volume":"15","author":"HQ Rana","year":"2012","unstructured":"Rana HQ, Balwani M, Bier L, Alcalay RN (2012) Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling. Genet Med 15:146\u2013149","journal-title":"Genet Med"},{"key":"8908_CR4","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa033277","volume":"351","author":"J Aharon-Peretz","year":"2004","unstructured":"Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R (2004) Mutations in the glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med 351:1972\u20131977","journal-title":"N Engl J Med"},{"key":"8908_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/mds.20766","volume":"21","author":"MJ Eblan","year":"2006","unstructured":"Eblan MJ, Nguyen J, Ziegler SG, Lwin A, Hanson M, Gallardo M et al (2006) Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela. Mov Disord 21:282\u2013283","journal-title":"Mov Disord"},{"issue":"1","key":"8908_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","volume":"81","author":"A Lwin","year":"2004","unstructured":"Lwin A, Orvisky E, Goker-Alpan O, LaMarca ME, Sidransky E (2004) Glucocerebrosidase mutations in subjects with parkinsonism. Molecular Genet Metabol 81(1):70\u201373","journal-title":"Molecular Genet Metabol"},{"key":"8908_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/archneurol.2009.72","volume":"66","author":"J Mitsui","year":"2009","unstructured":"Mitsui J, Mizuta I, Toyoda A, Ashida R, Takahashi Y, Goto J et al (2009) Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 66:571\u2013576","journal-title":"Arch Neurol"},{"key":"8908_CR8","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/brain\/awp044","volume":"132","author":"J Neumann","year":"2009","unstructured":"Neumann J, Bras J, Deas E, O\u2019Sullivan SS, Parkkinen L, Lachmann RH et al (2009) Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease. Brain 132:1783\u20131794","journal-title":"Brain"},{"issue":"4","key":"8908_CR9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1212\/01.wnl.0000327823.81237.d1","volume":"72","author":"WC Nichols","year":"2009","unstructured":"Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser V, Halter C, Rudolph A, Wojcieszek J, Pfeiffer R, Foroud T, Investigators. PSG-P. (2009) Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology 72(4):310\u2013316","journal-title":"Neurology"},{"issue":"1","key":"8908_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bcmd.2010.10.006","volume":"46","author":"B Rosenbloom","year":"2011","unstructured":"Rosenbloom B, Balwani M, Bronstein JM (2011) The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry. Blood Cells Molecules Disease 46(1):95\u2013102","journal-title":"Blood Cells Molecules Disease"},{"key":"8908_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/jnnp.2006.111518","volume":"79","author":"JL Capablo","year":"2008","unstructured":"Capablo JL, Saenz de Cabez\u00f3n A, Fraile J, Alfonso P, Pocovi M, Giraldo P et al (2008) Neurological evaluation of patients with Gaucher disease diagnosed as type 1. J Neurol Neurosurg Psychiatr 79:219\u2013222","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"8908_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","volume":"89","author":"O Neudorfer","year":"1996","unstructured":"Neudorfer O, Giladi N, Elstein D, Abrahamov A, Turezkite T, Aghai E et al (1996) Occurrence of Parkinson\u2019s syndrome in type 1 Gaucher disease. QJM 89:691\u2013694","journal-title":"QJM"},{"key":"8908_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","volume":"79","author":"N Tayebi","year":"2003","unstructured":"Tayebi N (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79:104\u2013109","journal-title":"Mol Genet Metab"},{"issue":"1","key":"8908_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/01.WNL.0000072482.70963.D7","volume":"61","author":"B Bembi","year":"2003","unstructured":"Bembi B, Marsala SZ, Sidransky E, Ciana G (2003) Gaucher\u2019s disease with Parkinson\u2019s disease Clinical and pathological aspects. Neurology 61(1):99\u2013101","journal-title":"Neurology"},{"key":"8908_CR15","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson\u2019s disease. Lancet 373:2055\u20132066","journal-title":"Lancet"},{"key":"8908_CR16","first-page":"299","volume":"4","author":"TM Cox","year":"2010","unstructured":"Cox TM (2010) Gaucher disease: clinical profile and therapeutic developments. Biologics 4:299\u2013313","journal-title":"Biologics"},{"issue":"3","key":"8908_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneurol.2007.68","volume":"65","author":"IF Mata","year":"2008","unstructured":"Mata IF, Samii A, Schneer SH, Roberts JW, Griffith A, Leis B, Schellenberg G, Sidransky E, Bird T, Leverenz J, Tsuang D, and CP., Z (2008) Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Archives of neurology 65(3):379\u2013382","journal-title":"Archives of neurology"},{"key":"8908_CR18","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/gps.1610","volume":"21","author":"E Mioshi","year":"2006","unstructured":"Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke\u2019s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078\u20131085","journal-title":"Int J Geriatr Psychiatry"},{"key":"8908_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state.\u201d A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"8908_CR20","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","volume":"55","author":"B Dubois","year":"2000","unstructured":"Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB A frontal assessment battery at bedside. Neurology 55:1621\u20131626","journal-title":"Neurology"},{"key":"8908_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0010-440X(61)80020-5","volume":"2","author":"AT Beck","year":"1961","unstructured":"Beck AT (1961) A systematic investigation of depression. Compr Psychiatry 2:163\u2013170","journal-title":"Compr Psychiatry"},{"issue":"2","key":"8908_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-V","volume":"38","author":"RS Marin","year":"1991","unstructured":"Marin RS, Biedrzycki RC, Firinciogullari S (1991) Reliability and validity of the apathy evaluation scale. Psychiatry Res 38(2):143\u2013162","journal-title":"Psychiatry Res"},{"key":"8908_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpeds.2007.12.023","volume":"153","author":"O Goker-Alpan","year":"2008","unstructured":"Goker-Alpan O, Wiggs EA, Eblan MJ, Benko W, Ziegler SG, Sidransky E et al (2008) Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease. J Pediatr 153:89\u201394.e4","journal-title":"J Pediatr"},{"issue":"3","key":"8908_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/brain\/awh067","volume":"127","author":"T Foltynie","year":"2004","unstructured":"Foltynie T, Brayne C, Robbins TW, Barker RA (2004) The cognitive ability of an incident cohort of Parkinson\u2019s patients in the UK. The CamPaIGN study. Brain 127(3):550\u2013560","journal-title":"Brain"},{"issue":"4","key":"8908_CR25","first-page":"483","volume":"70","author":"TA Ala","year":"2001","unstructured":"Ala TA, Hughes LF, Kyrouac GA (2001) Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer\u2019s disease. J Neurol 70(4):483\u2013488","journal-title":"J Neurol"},{"key":"8908_CR26","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1001\/jamaneurol.2014.313","volume":"71","author":"RN Alcalay","year":"2014","unstructured":"Alcalay RN, Dinur T, Quinn T, Sakanaka K, Levy O, Waters C et al (2014) Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes. JAMA Neurol 71:752\u2013757","journal-title":"JAMA Neurol"},{"issue":"8","key":"8908_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3109\/07853890.2013.849003","volume":"45","author":"MS Beavan","year":"2013","unstructured":"Beavan MS, Schapira A (2013) Glucocerebrosidase mutations and the pathogenesis of Parkinson disease. Ann Med 45(8):511\u2013521","journal-title":"Ann Med"},{"key":"8908_CR28","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1212\/NXG.0000000000000057","volume":"2","author":"G Lopez","year":"2016","unstructured":"Lopez G, Kim J, Wiggs E, Cintron D, Groden C, Tayebi N et al (2016) Clinical course and prognosis in patients with Gaucher disease and parkinsonism. Neurol Genet 2:e57","journal-title":"Neurol Genet"},{"key":"8908_CR29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/brain\/aws318","volume":"136","author":"SE Winder-Rhodes","year":"2013","unstructured":"Winder-Rhodes SE, Evans JR, Ban M, Mason SL, Williams-Gray CH, Foltynie T et al (2013) Glucocerebrosidase mutations influence the natural history of Parkinson\u2019s disease in a community-based incident cohort. Brain 136:392\u2013399","journal-title":"Brain"},{"key":"8908_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/mds.26071","volume":"30","author":"K Brockmann","year":"2014","unstructured":"Brockmann K, Srulijes K, Pflederer S, Hauser A-K, Schulte C, Maetzler W et al (2014) GBA-associated Parkinson\u2019s disease: Reduced survival and more rapid progression in a prospective longitudinal study. Mov Disord 30:407\u2013411","journal-title":"Mov Disord"},{"issue":"1","key":"8908_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/mds.26359","volume":"31","author":"IF Mata","year":"2015","unstructured":"Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, Bernard B, Espay AJ, Revilla FJ, Devoto J, Rosenthal LS, Dawson TM, Albert MS, Tsuang D, Huston H, Yearout D, Hu S-C, Cholerton BA, Montine TJ, Edwards KL, Zabetian CP (2015) GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson\u2019s disease. Mov Disord 31(1):95\u2013102","journal-title":"Mov Disord"},{"key":"8908_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ymgme.2014.09.011","volume":"114","author":"EL Aronovich","year":"2015","unstructured":"Aronovich EL, Hackett PB (2015) Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier. Mol Genet Metab 114:83\u201393","journal-title":"Mol Genet Metab"},{"key":"8908_CR33","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.26563","volume":"31","author":"CH Williams-Gray","year":"2016","unstructured":"Williams-Gray CH, Wijeyekoon R, Yarnall AJ, Lawson RA, Breen DP, Evans JR et al (2016) Serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD). Mov Disord 31:995\u20131003","journal-title":"Mov Disord"},{"key":"8908_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ana.20369","volume":"57","author":"R Kortekaas","year":"2005","unstructured":"Kortekaas R, Leenders KL, van Oostrom JCH, Vaalburg W, Bart J, Willemsen ATM et al (2005) Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 57:176\u2013179","journal-title":"Ann Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-8908-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8908-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8908-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T20:39:25Z","timestamp":1559075965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-8908-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["8908"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-8908-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]},"assertion":[{"value":"15 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}